XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Note 8 - Net Income Per Share
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 8 – Net Income Per Share:

 

The Company’s basic net income per share is computed based on the weighted average number of shares of common stock outstanding for the period. Diluted net income per share includes the effect of the Company’s outstanding stock options, stock appreciation rights, nonvested shares of restricted stock and nonvested performance shares, if the inclusion of these items is dilutive.

 

The following table presents a reconciliation of basic and diluted net income per share for the periods presented:

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2024

   

2023

   

2024

   

2023

 

Net income used in the computation of basic and diluted net income per share (in thousands)

  $ 5,403     $ 3,114     $ 9,915     $ 5,215  
                                 

Weighted average shares outstanding - basic

    16,107,549       15,992,792       16,118,885       15,954,264  

Dilutive common stock equivalents

    436,441       162,563       470,029       178,568  

Weighted average shares outstanding - diluted

    16,543,990       16,155,355       16,588,914       16,132,832  

Net income per share:

                               

Basic

  $ 0.34     $ 0.19     $ 0.62     $ 0.33  

Diluted

  $ 0.33     $ 0.19     $ 0.60     $ 0.32  

 

Awards to purchase 309,778 and 1,198,603 shares of common stock with weighted average exercise prices of $21.44 and $15.32 per share were outstanding during the three months ended September 30, 2024 and 2023, respectively, but were not included in the computation of diluted net income per share because the awards’ exercise prices were greater than the average market price of the common shares.

 

Awards to purchase 335,071 and 1,158,819 shares of common stock with weighted average exercise prices of $21.40 and $15.84 per share were outstanding during the nine months ended September 30, 2024 and 2023, respectively, but were not included in the computation of diluted net income per share because the awards’ exercise prices were greater than the average market price of the common shares.